1. Home
  2. SCLX vs HGBL Comparison

SCLX vs HGBL Comparison

Compare SCLX & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.57

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

N/A

Current Price

$1.39

Market Cap

46.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
HGBL
Founded
2011
1937
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
46.9M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
SCLX
HGBL
Price
$6.57
$1.39
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$4.50
AVG Volume (30 Days)
30.1K
83.7K
Earning Date
05-13-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
N/A
$20,129,000.00
Revenue This Year
N/A
$10.19
Revenue Next Year
$749.70
$8.51
P/E Ratio
N/A
$13.50
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$1.13
52 Week High
$34.27
$2.32

Technical Indicators

Market Signals
Indicator
SCLX
HGBL
Relative Strength Index (RSI) 30.61 55.98
Support Level $4.56 $1.23
Resistance Level $7.50 $1.44
Average True Range (ATR) 0.64 0.08
MACD -0.13 0.02
Stochastic Oscillator 0.00 71.19

Price Performance

Historical Comparison
SCLX
HGBL

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: